Related Experiment Video
Updated: Feb 14, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Novel polymorph of ambrisentan: Characterization and stability
Jamshed Haneef1, Renu Chadha1, Vijay Gupta2
1University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Studies (CAS), Panjab University, Chandigarh 160 014, India.
A new polymorph of ambrisentan (form II) was discovered, exhibiting 1.5-fold higher solubility than the commercial form. However, form II converts to the commercial form under various conditions.
Area of Science:
- Pharmaceutical Sciences
- Solid-State Chemistry
- Drug Development
Background:
- Ambrisentan (AMT) is a selective endothelin type A (ETA) receptor antagonist crucial for treating pulmonary arterial hypertension (PAH).
- Understanding different solid-state forms (polymorphs) of active pharmaceutical ingredients is vital for optimizing drug efficacy and formulation.
Purpose of the Study:
- To identify and characterize a novel polymorph of ambrisentan (AMT).
- To evaluate the physicochemical properties, particularly aqueous solubility, of the new polymorph compared to the commercial form.
- To investigate the solid-state stability and phase transformation behavior of the novel polymorph.
Main Methods:
- Isolation of the novel polymorph (form II) via solution crystallization.
- Characterization using differential scanning calorimetry, powder X-ray diffraction, solution calorimetry, and aqueous solubility studies.
- Single crystal X-ray diffraction to determine crystal structure and space group.
- Phase transformation studies (solution-mediated and stress-induced) and accelerated stability testing.
Main Results:
- A novel monoclinic polymorph of ambrisentan (form II, space group P21/c) was successfully isolated and characterized.
- Form II demonstrated a 1.5-fold higher apparent solubility in 0.1 N HCl (pH 1.2) compared to the commercial form I.
- Both solution-mediated and stress-induced phase transformations showed that form II converts to form I.
- Accelerated stability studies confirmed the conversion of form II to form I within one month at 40°C and 75% RH.
Conclusions:
- A new enantiotropically related polymorph of ambrisentan (form II) was identified with significantly improved aqueous solubility.
- Despite its enhanced solubility, form II is less stable and converts to the commercial form I under various conditions.
- Further research may be needed to stabilize form II or explore its therapeutic potential despite its transformation characteristics.
More Related Videos
Related Concept Videos
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Single Nucleotide Polymorphisms-SNPs
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Stability of structures

